Novavax stockNVAX
Novavax trades at $9.78, 26.9% below its 52-week high (Oct 5, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +45.5% year to date, +27.2% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
Ratings, candles, signals and the screener for NVAX — after you log in
Open the terminalFrequently asked questions about Novavax
What is the Novavax stock price?
At the close on Nov 5, 2026: $9.78 (−8.17% on the day). 52-week high: $13.38 on Oct 5, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Novavax report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed +85% year over year, revenue −3%.
Does Novavax pay dividends?
No, Novavax does not pay dividends.
Where does Novavax trade and how to buy it?
Ticker NVAX, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Novavax now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for NVAX are in the terminal after you log in.